University Medicine Greifswald

At University Medicine Greifswald, research in Innere Medizin C focuses on blood cancers and related malignancies, with studies aimed at improving outcomes for patients with aggressive lymphoma and nasopharyngeal carcinoma.

• Evaluating whether a new treatment combination can extend disease control in older adults with previously untreated diffuse large B-cell lymphoma.
• Assessing whether treatment can improve response rates in EBV-positive nasopharyngeal carcinoma so that radiotherapy intensity may be safely reduced.

The site’s clinical trials are centered on testing better cancer therapies and refining treatment strategies to balance effectiveness with long-term patient well-being.

Clinical research at this hospital clinic is exploring new ways to treat complex B-cell lymphoma subtypes, including difficult-to-manage forms such as DLBCL and related high-grade variants.

• Testing whether adding an additional targeted therapy can improve progression-free survival in patients who are not eligible for standard full-intensity chemotherapy.
• Studying treatment response in a broad range of large B-cell lymphoma subtypes to support more effective care for these rare diseases.

This research reflects a strong interest in improving treatment effectiveness for hematologic cancers while adapting therapy to patient age and clinical needs.